Epidemiology, comparative methods of detection, and preventability of adverse drug events

Annals of Pharmacotherapy

Volumn 39, Issue 7-8, 2005, Pages 1169-1174

  Al Tajir, Ghada K ^a,c   Kelly, William N ^b  

^a Qassimi Hospital   (United Arab Emirates)

^b William N Kelly Consulting Inc   (United States)

^c NONE   (United Arab Emirates)

Author keywords

Adverse drug event; Detection methods; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; ENOXAPARIN; FUROSEMIDE; GASTROINTESTINAL AGENT; IBUPROFEN; INSULIN; PARACETAMOL; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE SEVERITY; DRUG SURVEILLANCE PROGRAM; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; PATIENT CARE; PRIORITY JOURNAL; SIDE EFFECT; UNITED ARAB EMIRATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; COHORT STUDIES; DATA COLLECTION; DECISION SUPPORT SYSTEMS, CLINICAL; DOCUMENTATION; HOSPITALS; HUMANS; IATROGENIC DISEASE; PHARMACEUTICAL PREPARATIONS; PHARMACY SERVICE, HOSPITAL; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; UNITED ARAB EMIRATES;

EID: 21744457787     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E559     Document Type: Article

References (31)

1. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991;324:377-84.
2. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse events. Implications for prevention. JAMA 1995;274:29-34.
3. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998;165:405-8.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998;279:1200-5.
5. Pouyanne P, Haramburu F, Imbs JL, Bégaud B, for the French Pharmacovigilance Centres. Admissions to hospital caused by adverse drug reaction: cross sectional incidence study. BMJ 2000;320:1036.
6. Classen DC, Pestonik SL, Evans S. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6.
7. Lindquist R, Gersema LM. Understanding and preventing adverse drug events. AACN Clin Issues 1998;9:119-28.
8. Kelly WN. Potential risks and prevention, part 4: reports of significant adverse drug events. Am J Health Syst Pharm 2001;58:1406-12.
9. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmonson A, Leape LL. Preventable adverse events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997;25:1289-97.
10. Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-20.
11. Levy M, Kewitz II, Altwein W, Hillebrand J, Eliakim M. Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol 1980;17:23-31.
12. Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol 1998;38:1003-9.
13. Senst BL, Achusim LE, Genest RP, Cosentino LA, Ford CC, Little JA, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001;58: 1126-32.
14. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Peterson LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307-11.
15. Uppal R, Jhaj R, Malhotra S. Adverse drug reactions among inpatients in a north Indian referral hospital. Natl Med J India 2000;13:16-8.
16. Malhotra S, Jain S. Pandhi P. Drug related visits to the medical emergency department: a prospective study from India. Int J Clin Pharmacol Ther 2001;39:8-12.
17. Major S, Badr S, Bahlawan L, Hassan G, Khogaoghlanian T, Khalil R, et al. Drug-related hospitalization at a tertiary teaching center in Lebanon: incidence, associations and relation to self-medicating behavior. Clin Pharmacol Ther 1998;64:450-61.
18. Ahmed M el-B. Drug-associated admissions to a district hospital in Saudi Arabia. J Clin Pharm Ther 1997;22:61-6.
19. Reporting adverse drug reactions. Geneva: World Health Organization, 1999.
20. Gandi TK, Bates DW. Computer adverse drug event (ADE) detection and alerts. In: Making healthcare safer: a critical analysis of patient safety practices. Rockville, MD: Agency for Healthcare Research and Quality. July, 2001.
21. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
22. Hansten PD, Horn JR. Hansten and Horn's drug interactions analysis and management. St. Louis: Facts and Comparisons, 2000.
23. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27:538.
24. Forster AJ, Haul RB, Tierney MG. Pharmacist surveillance of adverse drug events. Am J Health Syst Pharrn 2004;61:1466-72.
25. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003;60:1750-9.
26. Bennett BS. Lipman AG. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm 1977;34:931-6.
27. Winterstein AAAG, Hatton RC, Gonzalez-Rothi R, Johns ET, Segal R. Identifying clinically significant adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm 2002;59:1742-9.
28. Kelly WN. The quality of published adverse drug event reports. Pharmacotherapy 2003;37:1774-8.
29. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
30. van Der Bemt PM, Egberts AC, Lenderink AW, Verzijil JM, Simons KA, van der Pols WS, et al. Adverse events in hospitalized patients. A comparison of doctors, nurses and patients as sources of reports. Eur J Clin Pharmacol 1999;55:155-8.
31. Sum DS. A national survey of hospital adverse drug event monitoring and reporting systems. Drug Inf J 1996;30:973-85.